HealthEquity Appoints Noémie Heuland to Board; Board Expands

What Happened
HealthEquity, Inc. filed an 8-K reporting that on September 24, 2026 the Board appointed Noémie Heuland to serve as a director, expanding the Board from ten to eleven members. Ms. Heuland, who is Chief Financial Officer of Moody’s Corporation, will serve on HealthEquity’s Audit and Risk Committee and its Cybersecurity and Technology Committee. Her appointment is effective immediately and she will receive HealthEquity’s standard non-employee director compensation and enter the company’s standard indemnification agreement.

Key Details

• Appointment effective: September 24, 2026; Board size increased to 11 members.
• Committee assignments: Audit and Risk Committee; Cybersecurity and Technology Committee.
• Related-party disclosure: HealthEquity paid approximately $146,519 to Moody’s-controlled subsidiaries in the fiscal year ended Jan. 31, 2026 for ratings and data; the company expects to pay Moody’s-controlled subsidiaries more than $120,000 in the fiscal year ending Jan. 31, 2027.
• Compensation: Ms. Heuland will receive the company’s standard retainer fees and annual equity awards for non-employee directors under the existing policy.

Why It Matters
This filing informs investors of a board-level change and committee reinforcement in key oversight areas (audit/risk and cybersecurity). The disclosure that Ms. Heuland is CFO of Moody’s and that HealthEquity has paid — and expects to pay — Moody’s-controlled entities above the SEC reporting threshold provides transparency about a potential related-party business relationship. The appointment may influence board expertise on finance, risk and technology oversight, but the filing contains no operational or financial guidance changes.